|
1
|
Janikashvili N, Bonnotte B, Katsanis E and
Larmonier N: The dendritic cell-regulatory T lymphocyte crosstalk
contributes to tumor-induced tolerance. Clin Dev Immunol.
2011:4303942011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fahy RJ, Doseff AI and Wewers MD:
Spontaneous human monocyte apoptosis utilizes a caspase-3-dependent
pathway that is blocked by endotoxin and is independent of
caspase-1. J Immunol. 163:1755–1762. 1999.
|
|
3
|
Estaquier J and Ameisen JC: A role for
T-helper type-1 and type-2 cytokines in the regulation of human
monocyte apoptosis. Blood. 90:1618–1625. 1997.PubMed/NCBI
|
|
4
|
Ludewig B, Graf D, Gelderblom HR, Becker
Y, Kroczek RA and Pauli G: Spontaneous apoptosis of dendritic cells
is efficiently inhibited by TRAP (CD40-ligand) and TNF-alpha, but
strongly enhanced by interleukin-10. Eur J Immunol. 25:1943–1950.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
van der Leij J, van den Berg A, Harms G,
et al: Strongly enhanced IL-10 production using stable galectin-1
homodimers. Mol Immunol. 44:506–513. 2007.
|
|
6
|
van der Leij J, van den Berg A, Blokzijl
T, et al: Dimeric galectin-1 induces IL-10 production in
T-lymphocytes: an important tool in the regulation of the immune
response. J Pathol. 204:511–518. 2004.PubMed/NCBI
|
|
7
|
Kuo PL, Hung JY, Huang SK, et al: Lung
cancer-derived galectin-1 mediates dendritic cell anergy through
inhibitor of DNA binding 3/IL-10 signaling pathway. J Immunol.
186:1521–1530. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ilarregui JM, Croci DO, Bianco GA, et al:
Tolerogenic signals delivered by dendritic cells to T cells through
a galectin-1-driven immunoregulatory circuit involving interleukin
27 and interleukin 10. Nat Immunol. 10:981–991. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stowell SR, Qian Y, Karmakar S, et al:
Differential roles of galectin-1 and galectin-3 in regulating
leukocyte viability and cytokine secretion. J Immunol.
180:3091–3102. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Barrionuevo P, Beigier-Bompadre M,
Ilarregui JM, et al: A novel function for galectin-1 at the
crossroad of innate and adaptive immunity: galectin-1 regulates
monocyte/macrophage physiology through a nonapoptotic ERK-dependent
pathway. J Immunol. 178:436–445. 2007. View Article : Google Scholar
|
|
11
|
Welte K, Platzer E, Lu L, et al:
Purification and biochemical characterization of human pluripotent
hematopoietic colony-stimulating factor. Proc Natl Acad Sci USA.
82:1526–1530. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Romero-Weaver AL, Wan XS, Diffenderfer ES,
Lin L and Kennedy AR: Kinetics of neutrophils in mice exposed to
radiation and/or granulocyte colony-stimulating factor treatment.
Radiat Res. 180:177–188. 2013. View
Article : Google Scholar
|
|
13
|
Guo Y, Zhang H, Yang J, et al: Granulocyte
colony-stimulating factor improves alternative activation of
microglia under microenvironment of spinal cord injury.
Neuroscience. 15:2382013.PubMed/NCBI
|
|
14
|
Prakash A, Medhi B and Chopra K:
Granulocyte colony stimulating factor (GCSF) improves memory and
neurobehavior in an amyloid-β induced experimental model of
Alzheimer’s disease. Pharmacol Biochem Behav. 110:46–57.
2013.PubMed/NCBI
|
|
15
|
Doseff AI: Apoptosis: the sculptor of
development. Stem Cells Dev. 13:473–483. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kiener PA, Davis PM, Starling GC, et al:
Differential induction of apoptosis by Fas-Fas ligand interactions
in human monocytes and macrophages. J Exp Med. 185:1511–1516. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mangan DF, Robertson B and Wahl SM: IL-4
enhances programmed cell death (apoptosis) in stimulated human
monocytes. J Immunol. 148:1812–1816. 1992.PubMed/NCBI
|
|
18
|
Gaur U and Aggarwal BB: Regulation of
proliferation, survival and apoptosis by members of the TNF
superfamily. Biochem Pharmacol. 66:1403–1408. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Choi JK, Kim KH, Park H, Park SR and Choi
BH: Granulocyte macrophage-colony stimulating factor shows
anti-apoptotic activity in neural progenitor cells via
JAK/STAT5-Bcl-2 pathway. Apoptosis. 16:127–134. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Feldman GM, Rosenthal LA, Liu X, et al:
STAT5A-deficient mice demonstrate a defect in
granulocyte-macrophage colony-stimulating factor-induced
proliferation and gene expression. Blood. 90:1768–1776. 1997.
|
|
21
|
Donnelly RP, Crofford LJ, Freeman SL, et
al: Tissue-specific regulation of IL-6 production by IL-4.
Differential effects of IL-4 on nuclear factor-kappa B activity in
monocytes and fibroblasts. J Immunol. 151:5603–5612.
1993.PubMed/NCBI
|
|
22
|
Takeshita S, Gage JR, Kishimoto T,
Vredevoe DL and Martínez-Maza O: Differential regulation of IL-6
gene transcription and expression by IL-4 and IL-10 in human
monocytic cell lines. J Immunol. 156:2591–2598. 1996.PubMed/NCBI
|
|
23
|
Hashimoto SI, Komuro I, Yamada M and
Akagawa KS: IL-10 inhibits granulocyte-macrophage
colony-stimulating factor-dependent human monocyte survival at the
early stage of the culture and inhibits the generation of
macrophages. J Immunol. 167:3619–3625. 2001. View Article : Google Scholar
|
|
24
|
Schmidt M, Lügering N, Pauels HG,
Schulze-Osthoff K, Domschke W and Kucharzik T: IL-10 induces
apoptosis in human monocytes involving the CD95 receptor/ligand
pathway. Eur J Immunol. 30:1769–1777. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nguyen JT, Evans DP, Galvan M, et al: CD45
modulates galectin-1-induced T cell death: regulation by expression
of core 2 O-glycans. J Immunol. 167:5697–5707. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pang M, He J, Johnson P and Baum LG:
CD45-mediated fodrin cleavage during galectin-1 T cell death
promotes phagocytic clearance of dying cells. J Immunol.
182:7001–7008. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fulcher JA, Chang MH, Wang S, et al:
Galectin-1 co-clusters CD43/CD45 on dendritic cells and induces
cell activation and migration through Syk and protein kinase C
signaling. J Biol Chem. 284:26860–26870. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Perillo NL, Pace KE, Seilhamer JJ and Baum
LG: Apoptosis of T cells mediated by galectin-1. Nature.
378:736–739. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Stillman BN, Hsu DK, Pang M, et al:
Galectin-3 and galectin-1 bind distinct cell surface glycoprotein
receptors to induce T cell death. J Immunol. 176:778–789. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Garín MI, Chu CC, Golshayan D,
Cernuda-Morollón E, Wait R and Lechler RI: Galectin-1: a key
effector of regulation mediated by CD4+ CD25+
T cells. Blood. 109:2058–2065. 2007.PubMed/NCBI
|
|
31
|
Pace KE, Hahn HP, Pang M, Nguyen JT and
Baum LG: CD7 delivers a pro-apoptotic signal during
galectin-1-induced T cell death. J Immunol. 165:2331–2334. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Perillo NL, Uittenbogaart CH, Nguyen JT
and Baum LG: Galectin-1, an endogenous lectin produced by thymic
epithelial cells, induces apoptosis of human thymocytes. J Exp Med.
185:1851–1858. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Paclik D, Werner L, Guckelberger O,
Wiedenmann B and Sturm A: Galectins distinctively regulate central
monocyte and macrophage function. Cell Immunol. 271:97–103. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cedeno-Laurent F and Dimitroff CJ:
Galectin-1 research in T cell immunity: past, present and future.
Clin Immunol. 142:107–116. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
van der Leij J, van den Berg A, Harms G,
et al: Strongly enhanced IL-10 production using stable galectin-1
homodimers. Mol Immunol. 44:506–513. 2007.PubMed/NCBI
|
|
36
|
Stowell SR, Qian Y, Karmakar S, et al:
Differential roles of galectin-1 and galectin-3 in regulating
leukocyte viability and cytokine secretion. J Immunol.
180:3091–3102. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mangan DF and Wahl SM: Differential
regulation of human monocyte programmed cell death (apoptosis) by
chemotactic factors and pro-inflammatory cytokines. J Immunol.
147:3408–3412. 1991.PubMed/NCBI
|
|
38
|
Liu F, Wu HY, Wesselschmidt R, Kornaga T
and Link DC: Impaired production and increased apoptosis of
neutrophils in granulocyte colony-stimulating factor
receptor-deficient mice. Immunity. 5:491–501. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lieschke GJ, Grail D, Hodgson G, et al:
Mice lacking granulocyte colony-stimulating factor have chronic
neutropenia, granulocyte and macrophage progenitor cell deficiency,
and impaired neutrophil mobilization. Blood. 84:1737–1746.
1994.
|
|
40
|
Shim W, Mehta A, Lim SY, et al: G-CSF for
stem cell therapy in acute myocardial infarction: friend or foe?
Cardiovasc Res. 89:20–30. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schneider A, Krüger C, Steigleder T, et
al: The hematopoietic factor G-CSF is a neuronal ligand that
counteracts programmed cell death and drives neurogenesis. J Clin
Invest. 115:2083–2098. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
42
|
Schneider A, Kuhn HG and Schäbitz WR: A
role for G-CSF (granulocyte-colony stimulating factor) in the
central nervous system. Cell Cycle. 4:1753–1757. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Harada M, Qin Y, Takano H, et al: G-CSF
prevents cardiac remodeling after myocardial infarction by
activating the Jak-Stat pathway in cardiomyocytes. Nat Med.
11:305–311. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fukada T, Hibi M, Yamanaka Y, et al: Two
signals are necessary for cell proliferation induced by a cytokine
receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity.
5:449–460. 1996. View Article : Google Scholar : PubMed/NCBI
|
